Tuesday’s General Session featured presentations on abstracts that covered topics such as the clinical utility of molecular tumor profiling and imaging mass cytometry in triple-negative breast cancer.

A session on Tuesday explored how the effects of the pandemic will be felt throughout the breast cancer community for years to come.

In recognition of her trailblazing work in clinical cancer genetics, Judy E. Garber, MD, MPH, received the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research on Tuesday.

This year’s recipient of the Susan G. Komen® Brinker Award for Scientific Distinction in Basic Science, Carlos Caldas, MD, FMedSci, was honored for his groundbreaking work in breast cancer genomics.